Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway

Details for Australian Patent Application No. 2009338174 (hide)

Owner Biodesix, Inc.

Inventors Roder, Heinrich; Tsypin, Maxim; Grigorieva, Julia

Agent Spruson & Ferguson

Pub. Number AU-B-2009338174

PCT Pub. Number WO2010/085235

Priority 12/321,393 20.01.09 US

Filing date 20 November 2009

Wipo publication date 29 July 2010

Acceptance publication date 2 February 2012

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2010/085235 Priority application(s): WO2010/085235

2 February 2012 Application Accepted

  Published as AU-B-2009338174

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009338184-Precast wall panels and method of erecting a high-rise building using these panels

2009338173-Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway